Health Condition 1: L509- Urticaria, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with signs and symptoms of Urticaria Both male and female participants between the age group of 18-70 presenting with less than 50 wheals along with and symptoms such as itching, rashes, dermatographism
Exclusion criteria
Exclusion criteria: Participants on continuous allopathic medications for urticaria Participants having history of anaphylaxis and urticarial vasculitis Participants having drug allergy Participants with uncontrolled systemic illness Patients not co-operating with the study Pregnant women and lactating mothers Others dermatological conditions like contact dermatitis, allergic eczema, angioedema
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in severity of urticaria symptoms (itching, wheals,rashes,dermatographism)using a predefined symptom grading scaleTimepoint: from baseline to day 15, day 30, day 45 and day 60 | — |
Secondary
| Measure | Time frame |
|---|---|
| change in Urticaria Activity scoreTimepoint: during baseline (Day 1-7), during treatment (Day 39 -45), and end of study (Day 53 -59);Change in serum IgE levelsTimepoint: from Baseline (Day 0) to day 60 | — |
Countries
India
Contacts
Glocal College of Ayurvedic Medical Science and Research Centre